Unigene Laboratories, Inc. is a publicly traded, biopharmaceutical company that engages in the research, production, and delivery of peptide-related products for medical use. It focuses on the development of various peptide products for the treatment of osteoporosis, including nasal and oral calcitonin, and oral PTH. Unigene Laboratories was co-founded by Warren P. Levy, Ronald S. Levy, and Jay Levy in 1980 and has corporate offices, an R&D facility and a state-of-the-art recombinant manufacturing facility in New Jersey.